As of 2024-12-11, the Fair Value of Syndax Pharmaceuticals Inc (SNDX) is -17.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.94 USD, the upside of Syndax Pharmaceuticals Inc is -216.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -56.00 | -73.20 | 24.90 | -149.30 | -209.36 | -92.59 |
| YoY growth | 24.32% | -30.71% | 134.02% | -699.60% | -40.23% | -122.44% |
| Market Cap (mil) | 1,275.28 |
| P/E | |
| Forward P/E |
| EPS | -3.48 |
| Avg earnings growth rate | -122.44% |
| TTM earnings | -297.06 |